PATENT CLAIM ANALYSIS

Application Number: 15960441
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-09
Patent Classification: ["514", "263210"]

Abstract:
Pharmaceutical compositions comprising an antidiabetic agent as an active agent are provided. The present invention relates to pharmaceutical compositions comprising linagliptin or a pharmaceutically acceptable salt thereof as an active agent. The present invention also relates to process of preparation of pharmaceutical compositions comprising linagliptin or a pharmaceutically acceptable salt thereof. The present invention also relates to method of administering the compositions comprising linagliptin to a subject in need thereof.

Claim (Index 1):
A pharmaceutical composition comprising linagliptin as a sole active agent in an amount less than 5.0% w/w of the total weight of the composition, mannitol in an amount between 80.0 w/w to 90.0% w/w of the total weight of the composition, at least one binder and at least one disintegrant and optionally other pharmaceutically acceptable excipients present in the composition, with the proviso that the composition is free of pregelatinised starch.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 91.0
- Lexical Diversity: 2.17647
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14417992', '15767131', '13511771', '12683696', '15235575']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7149650145420291
- 35 USC 102 Novelty (BERT): 0.51814364385564
- Combined Prediction Score: 0.6952828774733901
- Mean Citation Score: 260.294604
- Max Citation Score: 292.4849200000001
- Similarity Product: 181.1624121021033

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test